Krystal Biotech Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $289.0K | $1.9M |
| FY2017 | $4.3M | $49.5M | $49.6M |
| FY2018 | — | $113.2M | $103.7M |
| FY2019 | — | $202.9M | $187.5M |
| FY2020 | — | $292.1M | $268.3M |
| FY2021 | — | $593.6M | $341.2M |
| FY2022 | — | $522.2M | $161.9M |
| FY2023 | — | $778.6M | $358.3M |
| FY2024 | — | $946.4M | $344.9M |
| FY2025 | — | $1.22B | $496.3M |